Nu-Med Plus (NUMD) Invested Capital (2011 - 2026)

Nu-Med Plus has disclosed Invested Capital across 16 years of filings, most recently posting $90.1 million for Q2 2026.

• In Q2 2026, Invested Capital rose 61520.37% year-over-year to $90.1 million; the TTM figure through Jun 2026 stood at $90.1 million (up 61520.37% YoY), while the FY2025 annual figure was $90.1 million, up 78382.48% from the prior year.
• Invested Capital came in at $90.1 million for Q2 2026 at Nu-Med Plus, roughly flat from $90.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $90.1 million in Q4 2025 to a low of -$200753.0 in Q3 2022.
• Average Invested Capital over 5 years is $10.5 million, with a median of -$85864.0 recorded in 2024.
• Year-over-year, Invested Capital plunged 881.86% in 2024 and soared 78382.48% in 2025.
• Over 5 years, Invested Capital stood at $71353.0 in 2022, then sank by 165.52% to -$46751.0 in 2023, then sank by 146.19% to -$115096.0 in 2024, then soared by 78382.48% to $90.1 million in 2025, then changed by 0.0% to $90.1 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $90.1 million in Q2 2026, $90.1 million in Q4 2025, and -$158660.0 in Q3 2025.